157 related articles for article (PubMed ID: 21462260)
1. Facilitated temporal summation of pain at spinal level in Parkinson's disease.
Perrotta A; Sandrini G; Serrao M; Buscone S; Tassorelli C; Tinazzi M; Zangaglia R; Pacchetti C; Bartolo M; Pierelli F; Martignoni E
Mov Disord; 2011 Feb; 26(3):442-8. PubMed ID: 21462260
[TBL] [Abstract][Full Text] [Related]
2. Pain sensitivity and clinical progression in Parkinson's disease.
Mylius V; Brebbermann J; Dohmann H; Engau I; Oertel WH; Möller JC
Mov Disord; 2011 Oct; 26(12):2220-5. PubMed ID: 21766333
[TBL] [Abstract][Full Text] [Related]
3. Pain intensity on and off levodopa in patients with Parkinson's disease.
Nebe A; Ebersbach G
Mov Disord; 2009 Jun; 24(8):1233-7. PubMed ID: 19412949
[TBL] [Abstract][Full Text] [Related]
4. Effect of levodopa on pain threshold in Parkinson's disease: a clinical and positron emission tomography study.
Brefel-Courbon C; Payoux P; Thalamas C; Ory F; Quelven I; Chollet F; Montastruc JL; Rascol O
Mov Disord; 2005 Dec; 20(12):1557-63. PubMed ID: 16078219
[TBL] [Abstract][Full Text] [Related]
5. Pain is common in Parkinson's disease.
Hanagasi HA; Akat S; Gurvit H; Yazici J; Emre M
Clin Neurol Neurosurg; 2011 Jan; 113(1):11-3. PubMed ID: 20800342
[TBL] [Abstract][Full Text] [Related]
6. Enhanced temporal pain processing in multiple system atrophy.
Perrotta A; Bolla M; Serrao M; Paparatti M; Tassorelli C; Pierelli F; Sandrini G
Neurosci Lett; 2013 Oct; 555():203-8. PubMed ID: 24076144
[TBL] [Abstract][Full Text] [Related]
7. Do dyskinesia and pain share common pathophysiological mechanisms in Parkinson's disease?
Lim SY; Farrell MJ; Gibson SJ; Helme RD; Lang AE; Evans AH
Mov Disord; 2008 Sep; 23(12):1689-95. PubMed ID: 18709675
[TBL] [Abstract][Full Text] [Related]
8. Pattern of subclinical pulmonary dysfunctions in Parkinson's disease and the effect of levodopa.
Pal PK; Sathyaprabha TN; Tuhina P; Thennarasu K
Mov Disord; 2007 Feb; 22(3):420-4. PubMed ID: 17230476
[TBL] [Abstract][Full Text] [Related]
9. Response to heat pain stimulation in idiopathic Parkinson's disease.
Nandhagopal R; Troiano AR; Mak E; Schulzer M; Bushnell MC; Stoessl AJ
Pain Med; 2010 Jun; 11(6):834-40. PubMed ID: 20624238
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease and pain--nondopaminergic mechanisms are likely to be important too.
Lim SY; Farrell MJ; Evans AH
Mov Disord; 2011 Jun; 26(7):1353-4. PubMed ID: 21449013
[No Abstract] [Full Text] [Related]
11. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
[TBL] [Abstract][Full Text] [Related]
12. Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia.
Stoffers D; Bosboom JL; Deijen JB; Wolters EC; Berendse HW; Stam CJ
Brain; 2007 Jul; 130(Pt 7):1847-60. PubMed ID: 17412733
[TBL] [Abstract][Full Text] [Related]
13. [Disturbance of micturition in Parkinson's disease].
Sakakibara R; Uchiyama T; Yoshiyama M; Hattori T
No To Shinkei; 2001 Nov; 53(11):1009-14. PubMed ID: 11761908
[No Abstract] [Full Text] [Related]
14. Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group.
Rascol O; Brooks DJ; Brunt ER; Korczyn AD; Poewe WH; Stocchi F
Mov Disord; 1998 Jan; 13(1):39-45. PubMed ID: 9452324
[TBL] [Abstract][Full Text] [Related]
15. Both L-DOPA and HFS-STN restore the enhanced group II spinal reflex excitation to a normal level in patients with Parkinson's disease.
Marchand-Pauvert V; Gerdelat-Mas A; Ory-Magne F; Calvas F; Mazevet D; Meunier S; Brefel-Courbon C; Vidailhet M; Simonetta-Moreau M
Clin Neurophysiol; 2011 May; 122(5):1019-26. PubMed ID: 20943434
[TBL] [Abstract][Full Text] [Related]
16. The effects of levodopa on word intelligibility in Parkinson's disease.
De Letter M; Santens P; Van Borsel J
J Commun Disord; 2005; 38(3):187-96. PubMed ID: 15748723
[TBL] [Abstract][Full Text] [Related]
17. Muscular pain in Parkinson's disease and nociceptive processing assessed with CO2 laser-evoked potentials.
Tinazzi M; Recchia S; Simonetto S; Tamburin S; Defazio G; Fiaschi A; Moretto G; Valeriani M
Mov Disord; 2010 Jan; 25(2):213-20. PubMed ID: 20063386
[TBL] [Abstract][Full Text] [Related]
18. Levodopa-induced dyskinesias in Parkinson's disease: is sensitization reversible?
Bejjani BP; Arnulf I; Demeret S; Damier P; Bonnet AM; Houeto JL; Agid Y
Ann Neurol; 2000 May; 47(5):655-8. PubMed ID: 10805339
[TBL] [Abstract][Full Text] [Related]
19. Bilateral impairments of skilled reach-to-eat in early Parkinson's disease patients presenting with unilateral or asymmetrical symptoms.
Doan JB; Melvin KG; Whishaw IQ; Suchowersky O
Behav Brain Res; 2008 Dec; 194(2):207-13. PubMed ID: 18692094
[TBL] [Abstract][Full Text] [Related]
20. [Experience with continuous levodopa enteral infusion (Duodopa(®)) in patients with advanced Parkinson's disease in a secondary level hospital].
Santos-García D; Macías M; Llaneza M; Fuster-Sanjurjo L; Echarri-Piudo A; Belmonte S; Blanco S
Neurologia; 2010; 25(9):536-43. PubMed ID: 21093702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
